Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine vs morphine for postoperative analgesia after posterior lumbar fusion surgery
ChiCTR2500109437Phase 4Not yet recruiting
- Sponsor
- Beijing Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tapentadol in postoperative pain (2 arms), sponsored by Beijing Hospital. Primary endpoint: Total opioid consumption within 48 hours postoperatively. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
tapentadol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500109437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109437.